Shaping of tumor and drug-resistant genomes by instability and selection (original) (raw)

References

• Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R and Howell SB . (1996). Cancer Res., 56, 3087–3090.
• Albertson DG . (2003). Breast Cancer Res. Treat. 78, 289–298.
• Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R and Bertino JR . (2002). Biochim. Biophys. Acta, 1587, 164–173.
• Bocker T, Ruschoff J and Fishel R . (1999). Biochim. Biophys. Acta, 1423, O1–O10.
• Chen Z-S, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H and Kruh GD . (2002). Cancer Res., 62, 3144–3150.
• Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML and Stark GR . (1998). Mol. Cell. Biol., 18, 536–545.
• Cole PD, Kamen BA, Gorlick R, Banerjee D, Smith AK, Magill E and Bertino J . (2001). Cancer Res., 61, 4599–4604.
• Coquelle A, Pipiras E, Toledo F, Buttin G and Debatisse M . (1997). Cell, 89, 215–225.
• Coquelle A, Toledo F, Stern S, Bieth A and Debatisse M . (1998). Mol. Cell, 2, 259–265.
• Duval A and Hamelin R . (2002). Cancer Res., 62, 2447–2454.
• Eshelman JR, Casey G, Kochera ME, Sedwick WD, Swinler SE, Veigl ML, Willson JKV, Schwartz S and Markowitz SD . (1998). Oncogene, 17, 719–725.
• Esteller M . (2000). Eur. J. Cancer, 36, 2294–2300.
• Fink D, Nebe LS, Norris PS, Baergen RN, Wilczynsk SP, Costa MJ, Haas M, Cannistra SA and Howell SB . (1998). Int. J. Cancer, 77, 741–746.
• Frouin I, Prosperi E, Denegri M, Negri C, Donzelli M, Rossi L, Riva F, Stefanini M and Scovassi AI . (2001). Eur. J. Cancer, 37, 1173–1180.
• Guan XY, Xu J, Anzick SL, Zhang H, Trent JM and Meltzer PS . (1996). Cancer Res., 56, 3446–3450.
• Hawn MT, Umar A, Carethers JM, Marra G, Kunkel TA, Boland CR and Koi M . (1995). Cancer Res., 55, 3721–3725.
• Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L and Kerem B . (2002). Cancer Cell, 1, 89–97.
• Innocente SA, Abrahamson JLA, Cogswell JP and Lee JM . (1999). Proc. Natl. Acad. Sci. USA, 96, 2147–2152.
• Jain AN, Tokuyasu T, Snijders AM, Segraves R, Albertson DG and Pinkel D . (2002). Genome Res., 12, 325–332.
• Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA and Boland CR . (1994). Cancer Res., 54, 4308–4312.
• Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, Mössner J and Engeland K . (2000). Nucleic Acids Res., 28, 4410–4418.
• Kuo MT, Vyas RC, Jiang L-X and Hittelman WN . (1994). Mol. Cell. Biol., 14, 5202–5211.
• Lin C-T, Lyu YL, Xiao H, Lin W-H and Whang-Pen J . (2001). Nucleic Acids Res., 29, 3304–3310.
• Loeb LA . (2001). Cancer Res., 61, 3230–3239.
• Matherly L . (2001). Prog. Nucl. Acid Res., 67, 131–162.
• Muleris M, Dutrillaux AM, Olschwang S, Salmon RJ and Dutrillaux B . (1995). Genes Chromosomes Cancer, 14, 223–226.
• Muleris M, Salmon RJ and Dutrillaux B . (1990). Cancer Genet. Cytogenet., 46, 143–156.
• Paulson TG, Almasan A, Brody LL and Wahl GM . (1998). Mol. Cell. Biol., 18, 3089–3100.
• Pelengaris S, Khan M and Evan GI . (2002). Cell, 109, 321–334.
• Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Zhai Y, Dairkee SH, Ljung B-M, Gray JW and Albertson DG . (1998). Nat. Genet., 20, 207–211.
• Pipiras E, Coquelle A, Bieth A and Debatisse M . (1998). EMBO J., 17, 325–333.
• Rabiner LR . (1989). Proc. IEEE, 27, 257–286.
• Remvikos Y, Vogt N, Muleris M, Salmon RJ, Malfoy B and Dutrillaux B . (1995). Genes Chromosomes Cancer, 12, 272–276.
• Rots MG, Pieters R, Peters GJ, Noordhuis P, van Zantwijk CH, Kaspers GJL, Hählen, Creutzig U, Veerman AJP and Jansen G . (1999). Blood, 93, 1677–1683.
• Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngibl HR, Rüschoff J and Hofstädter F . (1995). Cancer Res., 55, 6002–6005.
• Singer MJ, Mesner LD, Friedman CL, Trask BJ and Hamlin JL . (2000). Proc. Natl. Acad. Sci. USA, 97, 7921–7926.
• Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D and Albertson DG . (2001). Nat. Genet., 29, 263–264.
• Soulie P, Fourme E, Hamelin R, Asselain B, Salmon R-J, Dutrillaux B and Muleris M . (1999). Cancer Genet. Cytogenet., 115, 118–122.
• Srimatkandada S, Dube SK, Carmen M and Bertino JR . (2000). Oncol. Res., 12, 11–15.
• Sutherland GR . (1991). GATA, 8, 161–166.
• Sutherland GR, Baker E and Richards RI . (1998). Trends Genet., 14, 501–506.
• Sutherland GR and Richards RI . (1995). Curr. Opin. Genet. Dev., 5, 323–327.
• Takemura Y, Kobayashi H and Miyachi H . (1999). Anti-Cancer Drugs, 10, 677–683.
• Taylor WR and Stark GR . (2001). Oncogene, 20, 1803–1815.
• Turner FB, Taylor SM and Moran RG . (2000). J. Biol. Chem., 275, 35960–35968.
• Waldman FM, DeVries S, Chew KL, Moore II DH, Kerlikowske K and Ljung BM . (2000). J. Natl. Cancer Inst., 92, 313–320.
• Zeng H, Chen Z-S, Belinsky MG, Rea PA and Kruh GD . (2001). Cancer Res., 61, 7225–7232.
• Zhang L, Yu J, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B . (2001). Cancer Res., 61, 3801–3805.
• Zhu C, Mills KD, Ferguson DO, Lee C, Manis J, Fleming J, Gao Y, Morton CC and Alt FW . (2002). Cell, 109, 811–821.
• Zimonjic D, Brooks MW, Popescu N, Weinberg RA and Hahn WC . (2001). Cancer Res., 61, 8838–8844.

Download references